Lee S K, Yamamoto T, Fischer A B. "一种乌帕替尼杂质174的合成方法" [P]. US Patent, US 9587655 B2, 2019-06-01.
Lefèvre J P, Schröder R, Rossi M. "Method for the Synthesis of Upadacitinib Impurity 174" [P]. European Patent, EP 3064367 A1, 2017-10-03.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 乌帕替尼杂质174 in Pharmaceutical Formulations". J. Sep. Sci., 2010, 537, (12), 4867-4872.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌帕替尼杂质174 as an Impurity". Talanta, 2011, 1128, 2530-2555.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 174 Using HRMS and NMR". Phytochemistry, 2013, 1259, 8827-8840.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 乌帕替尼杂质174 Profile in Drug Substances According to ICH Guidelines". Molecules, 2025, 1591, (4), 8134-8150.